Your browser doesn't support javascript.
Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.
Shekhar, Skand; Copacino, Caroline E; Barrera, Francisco J; Hall, Janet E; Hannah-Shmouni, Fady.
  • Shekhar S; Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Copacino CE; Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health (NIH), Research Triangle Park, North Carolina, USA.
  • Barrera FJ; Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Hall JE; Endocrinology Division, Internal Medicine Department, University Hospital "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Hannah-Shmouni F; Plataforma INVEST-KER Unit Mayo Clinic (KER Unit Mexico), School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Ann Natl Acad Med Sci ; 56(2): 112-115, 2020 Apr.
Article in English | MEDLINE | ID: covidwho-882962
ABSTRACT
COVID-19 has affected millions of people across the world but disproportionately and severely affects persons with metabolic disorders such as obesity, diabetes mellitus and hypertension. In this brief review, we discuss the pathways of immune dysregulation that may lead to severe COVID-19 in persons with metabolic conditions.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Ann Natl Acad Med Sci Year: 2020 Document Type: Article Affiliation country: S-0040-1713346

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Ann Natl Acad Med Sci Year: 2020 Document Type: Article Affiliation country: S-0040-1713346